Hudson Bay Capital Management LP Has Trimmed Its Yahoo (YHOO) Position; Roundview Capital Has Lowered Its Gilead Sciences (GILD) Stake

June 19, 2017 - By Richard Conner

Roundview Capital Llc decreased Gilead Sciences Inc (GILD) stake by 39.4% reported in 2016Q4 SEC filing. Roundview Capital Llc sold 7,185 shares as Gilead Sciences Inc (GILD)’s stock declined 8.05%. The Roundview Capital Llc holds 11,051 shares with $791,000 value, down from 18,236 last quarter. Gilead Sciences Inc now has $83.90B valuation. The stock rose 1.21% or $0.77 reaching $64.89. About 4.00 million shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since June 19, 2016 and is downtrending. It has underperformed by 38.50% the S&P500.

Hudson Bay Capital Management Lp decreased Yahoo Inc (YHOO) stake by 63.21% reported in 2016Q4 SEC filing. Hudson Bay Capital Management Lp sold 4.97 million shares as Yahoo Inc (YHOO)’s stock rose 11.26%. The Hudson Bay Capital Management Lp holds 2.89 million shares with $111.92 million value, down from 7.87M last quarter. Yahoo Inc now has $52.21B valuation. The stock rose 3.63% or $1.91 reaching $54.49. About 17.55M shares traded. Altaba Inc (NASDAQ:YHOO) has risen 35.55% since June 19, 2016 and is uptrending. It has outperformed by 18.85% the S&P500.

Investors sentiment decreased to 0.72 in 2016 Q4. Its down 0.16, from 0.88 in 2016Q3. It fall, as 68 investors sold YHOO shares while 207 reduced holdings. 59 funds opened positions while 139 raised stakes. 663.52 million shares or 5.16% more from 630.97 million shares in 2016Q3 were reported. The Illinois-based Magnetar Fincl Lc has invested 0% in Altaba Inc (NASDAQ:AABA). Ameriprise holds 0.01% in Altaba Inc (NASDAQ:AABA) or 637,922 shares. Germany-based Allianz Asset Mgmt Ag has invested 0% in Altaba Inc (NASDAQ:AABA). Connor Clark Lunn Inv Management accumulated 294,050 shares. Ancient Art Ltd Partnership owns 565,000 shares. Qs Investors Ltd stated it has 0% in Altaba Inc (NASDAQ:AABA). Deutsche Bancorporation Ag holds 0.03% of its portfolio in Altaba Inc (NASDAQ:AABA) for 942,008 shares. Gabelli Funds Ltd Liability Corporation has invested 0.19% in Altaba Inc (NASDAQ:AABA). Canada Pension Plan Investment Board owns 2.75M shares. 2.02M were reported by California Pub Employees Retirement Sys. Credit Suisse Ag, a Switzerland-based fund reported 6.70M shares. Oxford Asset Management reported 257,725 shares. Indaba Management Limited Partnership holds 13.44% of its portfolio in Altaba Inc (NASDAQ:AABA) for 794,554 shares. Springowl Associate Limited Co accumulated 35,000 shares. Parkwood Ltd Co reported 10,285 shares stake.

Hudson Bay Capital Management Lp increased Salesforce Com Inc (Call) stake by 219,600 shares to 389,600 valued at $26.67M in 2016Q4. It also upped Health Care Select Sector Bw (XLV) stake by 84,197 shares and now owns 101,000 shares. Boeing Co (NYSE:BA) was raised too.

Among 33 analysts covering Yahoo! Inc. (NASDAQ:YHOO), 16 have Buy rating, 1 Sell and 16 Hold. Therefore 48% are positive. Yahoo! Inc. had 106 analyst reports since July 22, 2015 according to SRatingsIntel. The rating was downgraded by Jefferies to “Hold” on Friday, October 21. Citigroup maintained the shares of YHOO in report on Tuesday, July 19 with “Buy” rating. The rating was downgraded by Morgan Stanley on Tuesday, July 26 to “Equal-Weight”. The firm has “Neutral” rating given on Wednesday, October 21 by B. Riley & Co. The firm has “Outperform” rating given on Tuesday, July 26 by CLSA. The firm has “Sector Perform” rating given on Wednesday, October 19 by RBC Capital Markets. On Wednesday, September 9 the stock rating was maintained by Bank of America with “Buy”. The stock of Altaba Inc (NASDAQ:AABA) earned “Buy” rating by Axiom Capital on Monday, October 19. Barclays Capital maintained it with “Equal-Weight” rating and $38 target in Wednesday, April 20 report. Jefferies maintained the shares of YHOO in report on Tuesday, July 19 with “Buy” rating.

Since December 21, 2016, it had 0 insider buys, and 10 sales for $1.49 million activity. Utzschneider Lisa had sold 683 shares worth $26,446 on Friday, December 30.

Analysts await Gilead Sciences, Inc. (NASDAQ:GILD) to report earnings on July, 24. They expect $2.13 earnings per share, down 29.70% or $0.90 from last year’s $3.03 per share. GILD’s profit will be $2.75 billion for 7.62 P/E if the $2.13 EPS becomes a reality. After $2.20 actual earnings per share reported by Gilead Sciences, Inc. for the previous quarter, Wall Street now forecasts -3.18% negative EPS growth.

Among 27 analysts covering Gilead Sciences (NASDAQ:GILD), 18 have Buy rating, 0 Sell and 9 Hold. Therefore 67% are positive. Gilead Sciences had 65 analyst reports since July 29, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Wednesday, August 31 by Jefferies. The firm has “Buy” rating by UBS given on Friday, April 29. The rating was maintained by Piper Jaffray with “Overweight” on Friday, July 24. The rating was maintained by RBC Capital Markets on Wednesday, November 2 with “Outperform”. The firm has “Outperform” rating given on Wednesday, February 3 by Credit Suisse. Leerink Swann initiated the stock with “Outperform” rating in Friday, February 5 report. On Friday, April 29 the stock rating was downgraded by Maxim Group to “Hold”. The company was initiated on Wednesday, September 9 by Jefferies. The firm has “Market Perform” rating by Wells Fargo given on Friday, December 4. Needham downgraded the shares of GILD in report on Tuesday, July 26 to “Hold” rating.

Since January 3, 2017, it had 0 buys, and 11 insider sales for $33.68 million activity. The insider MARTIN JOHN C sold $5.32 million. Another trade for 9,943 shares valued at $668,667 was made by Cogan John Francis on Tuesday, May 9. 5,000 shares valued at $337,392 were sold by Alton Gregg H on Thursday, March 30. Another trade for 20,365 shares valued at $1.41M was made by WILSON GAYLE E on Thursday, February 23.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: